4//SEC Filing
DeVinney Erick Wayne 4
Accession 0000805928-25-000041
CIK 0000805928other
Filed
Mar 18, 8:00 PM ET
Accepted
Mar 19, 5:24 PM ET
Size
18.2 KB
Accession
0000805928-25-000041
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
DeVinney Erick Wayne
VP of Clin. & Trans. Sciences
Transactions
- Exercise/Conversion
Common Stock
2025-03-16+6,362→ 209,723 total - Exercise/Conversion
Common Stock
2025-03-16+23,150→ 232,873 total - Exercise/Conversion
Restricted Stock Units
2025-03-16−23,150→ 23,150 total→ Common Stock (23,150 underlying) - Exercise/Conversion
Common Stock
2025-03-16+2,950→ 203,361 total - Exercise/Conversion
Restricted Stock Units
2025-03-16−2,950→ 0 total→ Common Stock (2,950 underlying) - Sale
Common Stock
2025-03-19$17.50/sh−15,111$264,443→ 217,762 total - Exercise/Conversion
Restricted Stock Units
2025-03-16−6,362→ 6,363 total→ Common Stock (6,362 underlying)
Footnotes (7)
- [F1]This reflects the number of restricted stock units that became vested as of March 16, 2025.
- [F2]Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units on March 16, 2025. This sale does not represent a discretionary trade by the Reporting Person.
- [F3]The reported price in Column 4 is a weighted average sale price. These shares were sold on March 19, 2025 in multiple transactions at $17.50 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F4]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F5]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023, 25% of the aggregate shares vest on March 16, 2024, and 25% of the aggregate shares vest on March 16, 2025. Vested shares will be delivered to the reporting person upon the vesting date.
- [F6]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
- [F7]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2027 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2025 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
Documents
Issuer
Axogen, Inc.
CIK 0000805928
Entity typeother
Related Parties
1- filerCIK 0001595972
Filing Metadata
- Form type
- 4
- Filed
- Mar 18, 8:00 PM ET
- Accepted
- Mar 19, 5:24 PM ET
- Size
- 18.2 KB